Stephen A Hurly insider trades

Open-market stock purchases and sales by Stephen A Hurly, Chief Executive Officer at LAVA Therapeutics NV, from SEC Form 4 filings since Sep 20, 2016.

Recent trades

DateStockTradeValue
Nov 13, 2025LVTX LAVA Therapeutics NVSold (not open market)—
Nov 13, 2025LVTX LAVA Therapeutics NVSold (not open market)—

Companies traded

  • LVTX LAVA Therapeutics NV: other filings, last Nov 13, 2025
  • SESN Sesen Bio, Inc: other filings, last Jun 12, 2018
  • EBIO Eleven Biotherapeutics, Inc: other filings, last Apr 9, 2018

Get free alerts when Stephen A Hurly files a new trade →